James A. DeCaprio, MD

Articles by James A. DeCaprio, MD

Ann W. Silk, MD, MS, codirector, the Merkel Cell Carcinoma Center of Excellence, physician, Dana-Farber Cancer Institute; assistant professor, medicine, Harvard Medical School

Extending the Frontiers of Checkpoint Inhibition in Merkel Cell Carcinoma

ByAnn W. Silk, MD, MS,James A. DeCaprio, MD

February 14th 2024

In the treatment of unresectable or metastatic Merkel cell carcinoma, immune checkpoint inhibitors have activity and tolerability.

James A. DeCaprio, MD, of Dana-Farber Cancer Institute

Dr. DeCaprio on Raising Awareness in Merkel Cell Carcinoma

ByJames A. DeCaprio, MD

May 25th 2021

James A. DeCaprio, MD, discusses raising awareness in Merkel cell carcinoma.

Latest Updated Articles

Dr. DeCaprio on Raising Awareness in Merkel Cell Carcinoma
May 25th 2021

Trending on OncLive

FDA Approves Lirafugratinib for Pretreated, Locally Advanced or Metastatic Cholangiocarcinoma

Dr Mayer on the FDA Approval of Camizestrant for ESR1-Mutated Breast Cancer

Dr Kuykendall on the Significance of the FDA Approval of Rusfertide for Polycythemia Vera

Dr Kahl on Frontline Strategies for Avoiding Autologous Transplant in MCL